{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MAYNF"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAYNF","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAYNF\",,,,,undefined,":{"symbol":"MAYNF","market":"US","secType":"STK","nameCN":"Mayne Pharma Ltd.","latestPrice":3.515,"timestamp":1754424000000,"preClose":3.515,"halted":0,"volume":0,"delay":15,"floatShares":65962408,"shares":81147959,"eps":-1.013855,"marketStatus":"Not Yet Opened","change":0,"latestTime":"08-05 16:00:00 EDT Delay","open":3.515,"high":3.515,"low":3.515,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.013855,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1754467200000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"PINK LIMITED","adjPreClose":3.515,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAYNF\",,,,,undefined,":{"symbol":"MAYNF","floatShares":65962408,"roa":"-0.61%","roe":"-23.75%","lyrEps":-1.460039,"shares":81147959,"dividePrice":0,"high":3.515,"amplitude":0,"preClose":3.515,"low":3.515,"week52Low":2.415,"pbRate":"0.99","psRate":"1.06","week52High":4.6,"institutionHeld":0,"latestPrice":3.515,"eps":-1.013855,"divideRate":0,"volume":0,"delay":15,"ttmEps":-1.013855,"open":3.515,"prevYearClose":2.79,"prevWeekClose":3.515,"prevMonthClose":3.515,"prevQuarterClose":3.3303,"fiveDayClose":3.515,"twentyDayClose":3.33,"sixtyDayClose":4.185},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MAYNF\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MAYNF\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2555306200","title":"Positive Report for Mayne Pharma Group (MAYNF) from Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2555306200","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555306200?lang=en_us&edition=fundamental","pubTime":"2025-07-30 07:35","pubTimestamp":1753832122,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group received a Buy rating and a A$6.10 price target from Canaccord Genuity analyst Elyse Shapiro yesterday. The company’s shares clo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/positive-report-for-mayne-pharma-group-maynf-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/positive-report-for-mayne-pharma-group-maynf-from-canaccord-genuity-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAYNF","BK4007"],"gpt_icon":0},{"id":"2528725712","title":"Sol-Gel, Mayne Pharma enter product purchase agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2528725712","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528725712?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:45","pubTimestamp":1744893949,"startTime":"0","endTime":"0","summary":"Sol-Gel Technologies (SLGL) entered into a product purchase agreement with a subsidiary of Mayne Pharma Group (MAYNF) for the sale and exclusive li...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sol-gel-mayne-pharma-enter-product-purchase-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sol-gel-mayne-pharma-enter-product-purchase-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MAYNF","SLGL","BK4007"],"gpt_icon":0},{"id":"2514886705","title":"Mayne Pharma Group Ltd (MAYNF) (H1 2025) Earnings Call Highlights: Strong Growth in Women's ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2514886705","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514886705?lang=en_us&edition=fundamental","pubTime":"2025-02-26 17:00","pubTimestamp":1740560431,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Revenues increased by 13% to $213.1 million, driven by strong growth in the women's health segment.Gross margin expanded significantly to 61.4% from 56.3% in the prior corresponding period.Underlying EBITA rose by 288%, showcasing substantial improvement in profitability.Positive operating cash flow of $25.9 million from continued operations, a significant turnaround from a negative cash flow in the previous period.The women's health portfolio showed strong performance with revenues up 30% and direct contribution up 117%.Revenue from dermatology showed only modest growth of 1%, with competition affecting sales of certain products.International segment's direct contribution declined due to timing effects of shipments and production schedules.Despite improvements, the company faces ongoing challenges with legacy inventory returns affecting revenue in the women's health segment.A:  The turn","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mayne-pharma-group-ltd-maynf-090031789.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["MAYNF","MYX.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":3,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAYNF\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-02-26","symbol":"MAYNF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708923600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2023-01-18","symbol":"MAYNF","defaultRemindTime":1674052200000,"type":"split","dateTimestamp":1674018000000,"forFactor":20,"toFactor":1,"ratio":20},{"market":"US","date":"2023-01-18","symbol":"MAYNF","amount":0.076857,"defaultRemindTime":1674052200000,"name":"Mayne Pharma Ltd.","recordDate":"2023-01-27","payableDate":"2023-01-19","currency":"AUD","type":"dividend","dateTimestamp":1674018000000},{"market":"US","date":"2022-08-25","symbol":"MAYNF","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1661400000000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAYNF\",market:\"US\",,,undefined,":[{"executeDate":"2023-01-18","recordDate":"2023-01-19","paymentDate":"2023-01-27","value":0.076857,"currency":"AUD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAYNF\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1753675200000}}}